Cargando…
microRNA-20b-5p overexpression combing Pembrolizumab potentiates cancer cells to radiation therapy via repressing programmed death-ligand 1
Radiation therapy (RT) is widely applied in cancer treatment. The sensitivity of tumor cells to RT is the key to the treatment. This study probes the role and mechanism of miR-20b-5p in Pembrolizumab’s affecting the radiosensitivity of tumor cells. After Pembrolizumab treatment or cell transfection...
Autores principales: | Jiang, Kexin, Zou, Huawei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805988/ https://www.ncbi.nlm.nih.gov/pubmed/34968160 http://dx.doi.org/10.1080/21655979.2021.2014617 |
Ejemplares similares
-
First-line pembrolizumab in programmed death ligand 1 positive non-small cell lung cancer
por: Travert, Camille, et al.
Publicado: (2019) -
The Effect of Pembrolizumab in Absence of Programmed Death 1 Receptor
por: Al Attar, Layth, et al.
Publicado: (2018) -
A Josephson radiation comb generator
por: Solinas, P., et al.
Publicado: (2015) -
MicroRNA-125b-2 overexpression represses ectodermal differentiation of mouse embryonic stem cells
por: DENG, SHANSHAN, et al.
Publicado: (2015) -
Sustained response to pembrolizumab in recurrent perivascular epithelioid cell tumor with elevated expression of programmed death ligand: a case report
por: McBride, Ali, et al.
Publicado: (2021)